Status:
UNKNOWN
Intrabone Cord Blood Transplantation
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Hematological Malignancies
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the viability of intrabone administration of umbilical cord blood as allogenic transplantation for the treatment of hematologic malignancies.
Eligibility Criteria
Inclusion
- Hematological malignancies
- Indication of allogenic transplantation
- No suitable donor (related/unrelated)
- No suitable cord blood unit with enough cellularity for standard transplant
- Written informed consent
Exclusion
- ECOG \> 2
- Co-morbidities
- HIV positive serology
- Pregnancy or breastfeeding
- Psychiatric illness
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00838019
Start Date
February 1 2009
End Date
February 1 2011
Last Update
February 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BMT Unit Hematology Department Hospital Clinic
Barcelona, Barcelona, Spain, 08036